C. Yeates et al., CHARACTERIZATION OF A TRUNCATED PROGESTERONE-RECEPTOR PROTEIN IN BREAST-TUMORS, The Journal of clinical endocrinology and metabolism, 83(2), 1998, pp. 460-467
The progesterone receptor (PR) mediates the actions of progesterone in
the normal and malignant breast. PR is expressed as two proteins, PR
B and PR A, which are expressed in normal progesterone target tissues
and in breast cancers. A significant proportion of breast cancers cont
ain, in addition, a smaller PR protein of molecular mass 78 kDa (PR78k
Da). The significance of PR78kDa expression is unknown, and in particu
lar, there are no data on whether PR78kDa is able to bind ligand and t
herefore potentially exhibit transcriptional activity. If this smaller
PR species exhibits similar differences in function as have been evid
enced in vitro for PR A relative to PR B, it is possible that this PR
species may be an important component in determination of progesterone
response in breast cancer. The purpose of this study was to determine
whether the PR78kDa protein in breast tumors is able to bind ligand a
nd to determine whether posttranscriptional mechanisms contribute to i
ts formation in breast cancers. There was no evidence that PR78kDa was
derived from proteolytic activity of either PR B or PR A. Similarly,
although exon-deleted PR transcripts were detected (which could, if tr
anslated, give rise to a PR protein similar in size to PR78kDa), neith
er the abundance of such transcripts nor their relationship to levels
of expressed PR78kDa protein supported a role for exon deletion in for
mation of this truncated PR protein. PR78kDa was not recognized by an
antibody specific for PR B, indicating that, like PR A, it lacks the N
-terminal portion of PR. PR78kDa was able to bind the progestin ligand
, indicating that it may have transcriptional activity. In summary, th
is study has shown that a truncated PR protein, found in breast cancer
s, is ligand-binding and seems to be derived from PR A, indicating tha
t it may have a role in progesterone signaling, although a deeper unde
rstanding of its role, if any, in breast cancer remains to be establis
hed.